2.38
Edesa Biotech Inc Stock (EDSA) Latest News
H.C. Wainwright maintains $21 target on Edesa Biotech shares By Investing.com - Investing.com South Africa
Edesa Biotech completes US$15 million private placement - Fasken
Edesa Biotech files to sell 7.81M common shares for holders - MSN
Zacks Small Cap Boosts Earnings Estimates for Edesa Biotech - Defense World
EDSA: Raises 15 Million to Advance EB06 - Smartkarma
EDSA: Raises $15 Million to Advance EB06… - Yahoo Finance
Biotech Stocks To Keep An Eye OnFebruary 13th - MarketBeat
Biotech Stocks To Keep An Eye On – February 13th - Defense World
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewswire
Edesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing - TipRanks
Edesa Biotech Inc. (EDSA) reports earnings - Quartz
Edesa Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Edesa Biotech, Inc. SEC 10-Q Report - TradingView
Edesa Biotech Reports Q1 2025 Financial Results and Updates on EB06 Development for Vitiligo Treatment - Nasdaq
Edesa's Q1 Report Reveals Major Vitiligo Drug Progress: $15M Cash Injection Fuels FDA Push - StockTitan
US Penny Stocks To Watch In February 2025 - Simply Wall St
Edesa Biotech secures $15 million for clinical program By Investing.com - Investing.com Nigeria
Novartis to acquire Anthos Therapeutics for up to $3.1 billion - MSN
Edesa Biotech, Inc. announced that it has received $14.999992 million in funding from Velan Capital Investment Management LP and another investor - Marketscreener.com
H: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Edesa Biotech Inc (EDSA) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings - Benzinga
Stock market news: Moleculin Biotech +583.33%, Cloudastructure +105.68% among top gainers during midday trading - Business Upturn
Nasdaq Surges 150 Points; Cisco Earnings Top Views - Benzinga
Edesa Biotech shares jump on $15M private placement - MSN
Edesa Biotech (EDSA) Sees Sharp Stock Increase After Equity News - Stocks Telegraph
Stock market today: Moleculin Biotech +388.10%, Alpha Modus Holdings +156.52% among top gainers in early trading - Business Upturn
MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy - MSN
US Stocks Edge Higher; Producer Prices Increase In January - Benzinga
Truist maintains Buy on Genmab stock, price target at $50 - MSN
Edesa Biotech announces $15 million private placement - MSN
Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital - Financial Post
Edesa Biotech Announces $15.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Marketscreener.com
Edesa Biotech secures $15 million for clinical program - Investing.com India
Edesa Biotech Secures $15 Million in Private Placement to Advance Clinical Programs - TipRanks
Edesa Biotech announces $15M private placement priced at-the-market - TipRanks
Edesa Biotech Secures $15 Million for CXCL10 Antibody Program - TipRanks
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
Major Funding Alert: Edesa's $15M Deal Fuels Breakthrough Vitiligo Drug Development - StockTitan
Dallas City Council approves planning deal for 2026 World Cup - MSN
Mawson Finland announces private placement for up to C$5M - MSN
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - MSN
Jabil acquires CDMO Pii to support drug development customers - MSN
Obesity drug developer Aardvark files for IPO - MSN
EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo - Research Tree
EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo… - Yahoo Finance
Edesa Biotech Announces $4.36 million Registered Direct Offering - ACCESS Newswire
Is Raytheon the Best Defense and Aerospace Stock to Own in 2025? - The Globe and Mail
Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World
EDSA Stock Touches 52-Week Low at $1.69 Amid Market Challenges - Investing.com
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):